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Key messages
 Ź What is the experience of communicating a diag-
nosis of malignant pleural mesothelioma from the 
perspective of patients, family carers and health 
professionals?
 Ź Successfully communicating a diagnosis of me-
sothelioma relies on a complex balance of factors 
including consistency and continuity, honesty, envi-
ronment, resources and training. Access to a spe-
cialist nurse and being patient-centred facilitated 
diagnostic communication.
 Ź Getting the communication of a diagnosis of meso-
thelioma right can have an enduring impact on pa-
tient experience across the pathway.
AbstrAct
background Malignant pleural mesothelioma (MPM) is 
an aggressive cancer linked to asbestos exposure and 
inhalation. As with other cancers, receiving a diagnosis of 
MPM is challenging and distressing. Particular challenges 
are associated with communicating a diagnosis of MPM, 
including explaining the disease and its prognosis, 
treatment options and legal and inancial implications. 
Receiving A Diagnosis Of Mesothelioma (RADIO Meso) 
aimed to understand the experience of communicating a 
diagnosis of MPM from the perspective of patients, family 
carers and health professionals.
Methods This qualitative study comprised 31 individual 
interviews with patients, family carers and health 
professionals. This was followed by two group interviews 
(n=42) and an electronic consultation exercise (n=39).
results This study provides unique insight into the 
mesothelioma diagnostic experience of patients, family 
carers and health professionals. Key indings include 
the importance of regarding diagnosis as a process, and 
provision of continuity and consistency. The clinical nurse 
specialist and effective multidisciplinary team working 
provided vital contributions to successful mesothelioma 
diagnostic communication. Facilitators to diagnostic 
communication included honesty and timeliness in 
communication, partnership working and maintaining 
a patient-centred approach. Challenges to enhancing 
mesothelioma diagnosis communication included 
accessing ongoing training, ensuring a suitable clinical 
environment and being able to allocate appropriate time.
conclusion The RADIO Meso study highlights factors 
that inluence the communication of a diagnosis of MPM 
from the perspectives of individual patients and family 
carers. These indings provide the basis for a set of 
recommendations that can be used by health professionals 
to improve the MPM diagnostic experience.
IntroductIon
Malignant pleural mesothelioma (MPM) is 
an aggressive cancer linked to asbestos expo-
sure and inhalation. The UK has among the 
highest incidence with over 2700 new cases a 
year.1 Innovative medical, surgical and radio-
therapy approaches are emerging to improve 
length and quality of life; however, there are 
currently no curative treatments for MPM. 
In England, overall median survival is 9.5 
months. One-year and 3-year survival are 38% 
and 7% respectively.2
Receiving a diagnosis of cancer is distressing; 
however, a recent literature review indicated 
that there are particular challenges associated 
with communicating a diagnosis of MPM.3 
These challenges relate to explaining the diag-
nosis and prognosis, treatment options and 
legal and financial implications. The shock of 
receiving an MPM diagnosis can lead to poor 
psychological and social outcomes, including 
anxiety, depression and anger.4 5 Patients have 
reported that a predominant memory of diag-
nosis was one of hopelessness due to its incur-
able nature and lack of treatment options.6 
Balancing realistic expectations with hope 
and knowing how to share the information 
with their family have also been identified as 
difficult experiences to navigate during the 
diagnostic period.7 MPM has a latency period 
reported to be between 20 and 50 years. This 
long period of time from asbestos exposure to 
disease can also add to the struggle to under-
stand the MPM diagnosis.
Breaking bad news (BBN), such as commu-
nicating a diagnosis of MPM, is a complex and 
highly skilled activity.8 If done badly, it can 
impact on subsequent quality of life and well-
being.9 Recent research indicated that consid-
ering BBN as a process involving multiple 
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Table 1 RADIO Meso patient and carer interview 
participants
Participant ID Participant details
Patient 1 Man with mesothelioma
Patient 2 Woman with mesothelioma
Patient 3 Woman with mesothelioma
Patient 4 Woman with mesothelioma
Patient 5 Man with mesothelioma
Patient 6 Man with mesothelioma
Family carer 1 Daughter of man with mesothelioma
Family carer 2 Daughter of a man with mesothelioma
Family carer 3 Daughter of a man with mesothelioma
Family carer 4 Wife of a man with mesothelioma
Family carer 5 Daughter of a man with mesothelioma
Family carer 6 Daughter of a man with mesothelioma
Family carer 7 Wife of a man with mesothelioma
Family carer 8 Wife of a man with mesothelioma
Family carer 9 Daughter of a man with mesothelioma
RADIO Meso, Receiving A Diagnosis Of Mesothelioma.
episodes of information provision and supportive inter-
ventions is a useful approach and can facilitate good 
practice.10 11 This is in comparison to emphasising the 
single episode of care when bad news, such as a diagnosis, 
is confirmed. In this paper, when we refer to communi-
cating a diagnosis or diagnostic experience, we include 
the period of consultations, tests and procedures leading 
up to diagnosis, as well as the time after diagnosis when 
people are coming to terms with their condition and 
developing an understanding of it.
Despite the profound impact of receiving a MPM diag-
nosis, and the imperative for this communication to 
be conducted effectively, there has been little research 
to illuminate experience and inform practice. The 
Receiving A Diagnosis Of Mesothelioma (RADIO Meso) 
study was conducted to address this evidence gap. Using 
qualitative methods, RADIO Meso aimed to understand 
the experience of communicating a diagnosis of MPM 
from the perspective of patients, family carers and health 
professionals. These findings were then used to develop a 
set of recommendations to improve the MPM diagnostic 
experience. This paper presents the key findings from 
RADIO Meso that informed those recommendations.
Methods
This qualitative study comprised individual and group 
interviews, followed by a consultation exercise conducted 
electronically.
sampling and recruitment
Individual interviews
This study gathered the diagnostic experiences, percep-
tions and understandings of patients, family carers and 
health professionals. Purposive sampling was used to iden-
tify individual participants for interview. This enabled the 
recruitment of a range of patients and carers in terms of 
age, gender, time since diagnosis and treatment centre.
Eligible participants included a person, or family carer 
of someone, who:
 Ź Had received a diagnosis of mesothelioma between 3 
and 12 months ago.
 Ź Was not experiencing physical or emotional distress 
that would be aggravated by participation.
 Ź Was able to give informed consent.
 Ź Spoke English.
 Ź Was able to and wanted to share their experiences of 
diagnosis.
Patients and family carers were recruited differently 
to the health professional participants of RADIO Meso. 
This was to prevent potential bias that could occur if we 
recruited nurses and patients from the same hospital.
People with a mesothelioma diagnosis and family 
carers were invited to take part in an individual interview 
via study information circulated by Mesothelioma UK. 
Information was sent in mailshots,social media and news-
letters. People were asked to contact the Mesothelioma 
UK helpline if interested in participating. Helpline staff 
discussed the study and liaised with the research team if 
people were happy to participate. The interview sample 
comprised six patients (three men and three women), 
nine family carers (six daughters and three female part-
ners of patients) (table 1).
Recruitment of health professionals was conducted 
differently. To recruit health professionals, study infor-
mation and invitations to participate were sent by email 
to members of the National Lung Cancer Forum for 
Nurses (NLCFN) and the British Thoracic Oncology 
Group. Lung cancer nurse specialist (LCNS) recruited 
from NLCFN formed the majority of individual inter-
view staff participants (n=14). We did not recruit Meso-
thelioma clinical nurse specialists (CNSs). At the time of 
the study, there were 15 Mesothelioma CNSs in the UK 
supported by and linked to Mesothelioma UK. There are 
now 24. For most of the UK, people with mesothelioma 
form part of a LCNS caseload and do not have access 
to a Mesothelioma CNS. By recruiting LCNSs through 
NLCFN, our sample reflected service provision in most 
of the UK, and ensured the inclusion of those working 
in a range of settings with a range of experience. Unfor-
tunately, despite a reminder recruitment email, only one 
doctor was recruited. This limits the extent of the doctors 
data included in the sample. However, the one interview 
was included to enable the integration of some medical 
experience.
In all, 14 CNSs, one doctor and one support worker 
(table 2) are interviewed.
Group interviews
The group interviews aimed to test and expand on find-
ings from the individual interviews and move towards 
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Table 2 RADIO Meso staff interview participants
Participant 
ID Participant details
LCNS 1 In a team of 2 LCNSs at an NHS Hospital Trust 
in a town. In post 3 years.
LCNS 2 Single-handed LCNS in large NHS Hospital 
Trust in a city. Just awarded funding for 
additional LCNS post. In post 12 years.
LCNS 3 One of three LCNS in the team in an NHS 
Hospital Trust serving rural/town area. In post 
3 years
LCNS 4 One of three LCNS in the team in an NHS 
Hospital Trust serving rural/town area. In post 
12 months.
LCNS 5 One of two LCNS in the team in an NHS 
Hospital Trust serving rural/town area. In post 
over 18 years.
LCNS 6 Single-handed LCNS in an NHS Hospital Trust 
serving sea side town. In post 3 years.
LCNS 7 Single-handed LCNS in an NHS Hospital Trust 
serving rural area. In post 17 years.
LCNS 8 Ina team with three other LCNS in large NHS 
Hospital Trust in a city. Just awarded funding 
for additional LCNS post. In post 14 years.
LCNS 9 Single-handed LCNS in an NHS Hospital Trust 
serving rural area. In post 10 years.
LCNS 10 LCNS in an NHS Hospital Trust serving rural/
town area. In post 17 years.
LCNS 11 LCNS in large city NHS Teaching Hospital 
Trust in a team of 1.5 LCNSs. Works with 
one additional half time LCNS. In post 
approximately 5 years.
LCNS 12 LCNS in large city NHS Teaching Hospital 
Trust in a team with two other LCNSs. In post 
13 years.
LCNS 13 LCNS in large city NHS Teaching Hospital 
Trust. Trust covers two sites. LCNS 13 covers 
one site. In post 18 years.
LCNS 14 LCNS in large NHS Teaching Hospital in a 
team of 3 LCNSs. Been in post >20 years.
D 1 Respiratory consultant in NHS Teaching 
Hospital Trust.<3 years in post.
SW 1 A support worker in a team of three LCNS in 
an NHS Hospital Trust serving rural/town area. 
In post <3 years.
LCNS, lung cancer nurse specialist; NHS, National Health Service; 
RADIO Meso, Receiving A Diagnosis Of Mesothelioma.
the development of recommendations. The recommen-
dation development required participation of people 
with a degree of expertise. Two group interviews with 42 
participants were held adjacent to pre-existing meetings 
and events. One group (n=27) was scheduled within a 
patients and carers day organised by Mesothelioma UK. 
The other group was arranged within a UK Mesothelioma 
CNS meeting (n=15). Participants were informed about 
the study and the group interview event when they were 
provided with information about the event or meeting. 
Those who were interested attended the group interview 
and consent was obtained prior to this commencing.
Consultation
All individual interview participants were contacted to 
comment on the recommendations as part of the consul-
tation. Seven responses were obtained from the interview 
participants (one daughter, one wife, one patient, three 
CNSs and one doctor). In addition, members and users 
of Mesothelioma UK (service users) were asked to partic-
ipate in the consultation. In all, 32 Mesothelioma UK 
service users provided responses.
Data collection
Data collection took place between March 2017 and April 
2018.
Individual Interviews
Individual interviews were conducted over the telephone, 
following informed consent being obtained. Topic guides 
were developed following engagement with the available 
literature and consultation with both the advisory group 
and Patient and Public Involvement representatives. The 
topic guide contained questions on experiences of diag-
nostic communication, including prognosis, treatment 
and legal/financial implications (see box 1 for more 
detail).
Group interviews
Group interview participants were asked to share 
their experiences of communicating a mesothelioma 
diagnosis, particularly positive experiences as well as 
concerns. Participants recorded their thoughts in brief 
notes, which were used to guide the discussion and were 
later collected and collated. Participants also proposed 
recommendations for best practice regarding mesothe-
lioma diagnostic communication. Notes were taken by a 
member of the research team throughout the event to 
record the discussion.
Consultation methods
The national consultation was held between March and 
April 2018, inviting comments on the draft recommen-
dations. An electronic survey was shared via email and 
through various social media platforms, including the 
Mesothelioma UK online newsletter and website.
data handling and analysis
All individual interviews were digitally recorded with the 
participants' consent and the data were transcribed in full. 
Any identifying data were removed and the anonymised 
data were entered into QUIRKOS, a qualitative anal-
ysis software. QUIRKOS was used to store, manage and 
search the data. Data from the group interviews were also 
transcribed and uploaded into QUIRKOS for analysis.
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box 1. Initial topic guide for individual interviews with patients and family carers.
Initial topic guide for individual interviews with patients and family carers.
Welcome and introduction
 Ź Interview plan
 Ź Conirmation of consent
 Ź Statement of conidentiality
background information
 Ź Age
 Ź Family situation
 Ź Employment history
 Ź Length of time since diagnosis
 Ź Co-morbidities
Journey from symptoms to diagnosis
 Ź Symptoms
 Ź Diagnostic tests and investigations
 Ź Interactions with healthcare services
receiving the diagnosis
 Ź Who, where, what was said?
 Ź Understanding of the diagnosis, prognosis, treatments, legal and inancial implications
 Ź Response to and impact of diagnosis
relections on diagnosis experience
 Ź What was done well?
 Ź What could have improved your experience?
next steps following diagnosis
 Ź Hopes
 Ź What happened next
 Ź Expectations
now
 Ź Current health
 Ź Current treatment and care needs
 Ź Current information needs
 Ź Expectations and hope for the future
Additional comments
thanks for participation
Framework analysis was used throughout to interpret 
the data and identify key themes and issues relating to 
the diagnostic experience.12 The five stages of framework 
analysis (familiarisation, developing a thematic frame-
work, indexing, charting, and mapping and interpreta-
tion) were followed. This study was iterative in nature. 
Each stage built on the previous one, as demonstrated 
by figure 1. After the individual interviews, a provisional 
thematic framework was developed. This framework was 
revised following each stage of data collection. All data 
were analysed by two researchers (BT and AT). Following 
each stage, interpretations of the data were discussed and 
consensus achieved through discussion with the third 
researcher (CW). Having three stages of data collec-
tion and analysis (individual and group interviews and a 
consultation) helped to verify findings through triangu-
lation of methods. It also helped ensure saturation was 
achieved, that no new themes were emerging from the 
data.
Written informed consent was obtained from all partic-
ipants. The study was approved by The University of Shef-
field Research Ethics Committee.
results
An overview of the collated findings from all stages of 
the study are presented here, using the main themes as 
subheadings. These themes provided the basis for the 
recommendations that were summarised in an accessible 
document for health professionals (see figure 2).13
Impact of diagnosis
Underpinning all the results are the shock and devasta-
tion that all patients and family carers reported on being 
informed about the mesothelioma diagnosis (See box 2). 
For some participants, their reaction meant that they 
were unable to take in any additional information during 
the consultation and this had an impact on their subse-
quent information and support needs.
continuity and consistency
For many people, the road to diagnosis was long, and 
involved distressing symptoms and worrying periods of 
uncertainty as they went through the process of diagnostic 
tests and consultations (box 3). This finding supports the 
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Figure 1 RADIO Meso data generation and analysis. iMIG, 
International Mesothelioma Interest Group; RADIO Meso, 
Receiving A Diagnosis Of Mesothelioma.
Figure 2 10 top tips for communicating a diagnosis of 
mesothelioma.
box 2. Impact of diagnosis
“I don’t remember actually leaving and thinking, I don’t know enough. I think, at that point…at that point, you’re quite shocked and numb”. (Family 
carer 3)
“The initial diagnosis is obviously a shock for everybody and you need a little bit of time just to discuss it or talk about it. You go away, you know 
nothing. You don’t even know what mesothelioma is. I don’t think either one of us could spell it when we left”. (Patient 1)
proposal that should be seen as a process, not a moment 
in time. Ensuring continuity and consistency in terms of 
what is said by whom emerged as a key factor in providing 
good quality communication and care.
When pathways broke down, communication also 
became fractured. This had a distressing impact on 
patients and families. For example, when there was a 
delay in processing and communicating diagnostic test 
results, participant’s anxiety understandably increased.
the role of the cns
The continuity provided by a LCNS being accessible to 
patients throughout the diagnostic pathway was reported 
to improve the quality of the diagnosis experience (box 4). 
The LCNS was seen as being able to facilitate commu-
nication across the diagnostic pathway and between the 
multidisciplinary team (MDT) members. They explained 
what was happening and why, regarding diagnostic 
procedures, tests and appointments and tracked progress 
through these over the pathway. Participants highlighted 
that, if the impact of the LCNS is to be realised, local 
systems should ensure the CNS is informed as soon as a 
mesothelioma diagnosis is suspected, whether the person 
is an inpatient or outpatient.
specialist knowledge and training in mesothelioma and 
communication skills
Having specialist mesothelioma knowledge emerged as 
vital in enabling staff to clearly explain essential infor-
mation related to diagnosis including the condition, 
pending procedures, legal and financial implications, as 
well as treatment and clinical trial options (box 5).
Patients and carers explained that the way information 
was communicated was as important as the words used. 
Communication skills valued by participants in this study 
 o
n
 28 M
ay 2019 by guest. Protected by copyright.
http://bmjopenrespres.bmj.com/
BM
J O
pen Resp Res: first published as 10.1136/bmjresp-2019-000413 on 22 May 2019. Downloaded from 
6 Taylor BH, et al. BMJ Open Resp Res 2019;6:e000413. doi:10.1136/bmjresp-2019-000413
Open access
box 3. Continuity and consistency
“I think the fact that he had to then wait another two or 3 weeks for those results, was really hard… because obviously, during that time, everyone’s 
worried and you don’t know what it is and you don’t know what to expect, because no one had really prepared us for anything”. (Family carer 3).
“I think the pre-work you do, as in what you do in that irst consultation, the support you give them during the test and the results, and on the day 
you get the results. The ones where I feel it’s very different and where we don’t have an input or an impact is the inpatients… we’re not aware of 
what they’ve been told or what their expectations are. You might meet them for the irst time at diagnosis. That’s more dificult, when you’ve not got 
that relationship, when you’ve not got established contact and careful communication”. (LCNS 2)
“And that’s really the only criticism I suppose I’ve got, the fact that it took so long from January to May I was being seen by different doctors and, 
you know, I was supposed to have this scan and that scan and it didn’t happen and having to chase them up and it had been lost in wherever, you 
know what I mean, or whatever, so, you know, that made me, added to the anxiety I suppose really, because you know you’re ill, but you don’t know 
what’s wrong with you”. (Patient 3)
box 4. The role of the clinical nurse specialist
“And I do think as a nurse, especially because we get to know the patients as a person, not an illness, and I think it’s our role to be their advocate and 
to ight their corner”. (LCNS 7)
“The most expert form of contact was the specialist meso nurse. And I knew that she would be there, she told me, she’d be on the phone, and I 
could ring her anytime”. (Family carer 4)
included the ability to communicate in a warm, inclusive, 
respectful and participatory manner.
Staff participants valued regular training updates to 
support ongoing development of mesothelioma knowl-
edge and communications skills. Opportunities for 
supervision, reflection and learning from others were 
recommended to supplement formal training. However, 
there was evidence in the interviews that this was not 
always readily available or accessible. All the specialist 
nurse and medical participants had attended advanced 
communication training, in line with recommended 
practice since the 2000 National Health Service Cancer 
Plan.14 However, a concern was expressed about the 
absence of any follow-up communication training or 
supervision to support development and maintenance of 
diagnostic communication skills.
being patient-centred
The interview data revealed that people vary tremen-
dously in the amount of information they want to know 
and are able to assimilate when being given diagnostic 
information. Participant’s descriptions of their experi-
ences indicate that being skilled at listening, assessing 
what people know already, taking cues from body 
language and gauging people’s response to information 
is critical in helping identify what is appropriate to say, 
when and how. Although some patients and carers were 
keen to seek lots of information, some also highlighted 
that there was a risk of feeling overloaded with informa-
tion. Avoiding unnecessary medical terms and the use of 
technical language were seen as part of the process of 
personalising information provision (box 6).
Pathways, processes and experiences did vary across 
the health professionals who took part. However, all 
agreed that keeping the patient at the centre of services, 
practice and decision-making improved diagnostic 
communication. In short, making sure the patient feels 
that they are the most important person in the room, and 
at the centre of the communication process, was seen as 
a priority. If this occurs, the patient and family are more 
likely to access ongoing support and information to meet 
their needs across the diagnostic pathway.
Preparation and planning
Feeling prepared and having a plan were important for 
patients and carers in terms of knowing what to expect 
along the diagnostic pathway (box 7). Participant’s expe-
riences indicated how important it was for the healthcare 
team to be prepared prior to providing information about 
their diagnosis, including having a clear plan to present 
to the patient regarding the next steps. However, there 
were examples from all participant groups indicating 
that planning could be difficult due to the reality and 
constraints of everyday practice. Having good multi-dis-
ciplinary working relationships where everyone plays to 
their strengths is an advantage. Specialist MDTs were 
identified as positive examples of teamwork and instru-
mental in ensuring patients had a clear and appropriate 
plan, including access to relevant clinical trials.
environment
The importance of a quiet and private environment to 
facilitate communication was emphasised by patients and 
carers (box 8). However, many staff reported difficulties 
in achieving this due to the pressure on limited clinic 
space.
Strategies that were utilised by healthcare participants 
included using magnets or curtain clips to signify that a 
conversation should not be disturbed in inpatient areas 
and scheduling BBN appointments at the end of clinic 
when there is more privacy and less noise.
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box 5. Knowledge and training
“I mean her body language was very good; you know, she faced us head on, she didn’t look away, it was eye to eye contact. The Specialist Nurse was 
in the room with us as well, and they were behind us with their hand on our shoulders. It was the best it could have been, if you know what I mean”. 
(Family carer 8)
“I had personal clinical supervision, which I pay privately for, because I was recognising in this job you need to have someone to talk to …. There 
was talk about the advanced communication skills training was going to be kind of every 3 years, to be an update day, but that never happened, 
which is a real shame, because I think that would have been invaluable”. (LCNS 7)
“The only other thing is… some of our more junior… we had a more junior consultant, I would say, who seemed less familiar with mesothelioma 
and she… and the way she explained it to the patient, was that it was a mass. She explained it more like a tumour, rather than exactly what’s going 
on in this poor patient’s body. That caused… that really caused quite a lot of concern and a lot of conlict in the patient’s mind. That took a lot of 
unpicking. So, I think, because in our Trust, the consultants aren’t meeting that many patients, I think their knowledge sometimes isn’t as good as it 
can be. That’s something that I think…if I could, I would ensure that the consultants knew a lot more about it”. (LCNS 9)
box 6. Being patient-centred
So she was able to explain a lot of it and she used drawings and pictures and things to show me because I hadn't even got a clue, I didn't know 
anything about lungs. (Family carer 6)
We are very much guided by what they want. So you’re sat in that room with a relative usually, or two, and the patient. They usually all want to 
know varying degrees of information, from the thread to the needle. Some wanting to include prognosis, some not. And I think that’s the skill of our 
job, if there is a skill, which we need to very much gauge it to that audience (LCNS 2)
It’s an honour almost…sounds a bit corny, but it’s an honour to do it. It’s a very important time in that patient’s life and their families and they’re 
never going to forget it, and you can actually change the way they feel about things. You can make a difference, hopefully, a little bit of a difference 
that makes things a tiny bit easier for them. You just hope that that’s the difference you make. (LCNS 2)
time
Allocating appropriate time was seen as essential to good 
communication of a mesothelioma diagnosis. There 
were so many aspects to the diagnosis, and the impact was 
so profound that all participants recognised the appoint-
ment could not be rushed. Participants also described 
how creating a sense of time was important, for example, 
by listening, being patient-centred and not going through 
information like a checklist (box 9).
honesty
Many participants described how they considered it 
important for health professionals to achieve a balance 
between providing upsetting news with positives. The 
majority of patients said they preferred information to be 
given in a direct and honest way while maintaining hope 
at the same time (box 10).
Good effective MDT working was seen to be helpful in 
maintaining hope. Patients and families reported that 
knowing the MDT, a room of experts, had reviewed the 
patient’s case provided them with confidence related to 
the diagnosis, treatment plans and access to clinical trials.
Available expertise and resources
Participants’ accounts and experience indicated that no 
single clinician should carry the responsibility of commu-
nicating a diagnosis alone. There are a range of practi-
tioners and services, with varied expertise, that staff can 
refer to throughout the diagnostic process in order to aid 
the patient and carer experience (box 11). For example, 
Asbestos Advisory Services/Groups are often best placed 
to advise on benefits, compensation and legal claims. 
Resources from specialist organisations can be shared 
with patients to ensure up-to-date and good quality, 
accessible information and support. Examples include 
the information resources and telephone helpline devel-
oped and delivered by Mesothelioma UK.
dIscussIon
summary of key indings
This study provides unique insight into the experience of 
patients, family carers and health professionals regarding 
a mesothelioma diagnosis. The complexity of receiving 
a mesothelioma diagnosis and the devastating impact of 
this have been reported elsewhere.3–6 A key finding was 
the importance of regarding communicating a diagnosis 
as a process, rather than one episode of care. Providing 
continuity and consistency across that process in terms 
of what is said by whom was vital. The findings from this 
study highlight the importance of the LCNS in providing 
continuity and consistency prior to diagnostic confirma-
tion and following on from this. The recent National 
Mesothelioma Audit Report15 indicated that 93% of 
patients in Wales had access to a CNS. In contrast, CNS 
access in England was seen to vary by network from 28% 
to 62%. Although data completion for this item was low 
(66%), this audit finding raises questions regarding 
access to CNS support, advice and care, especially when 
RADIO Meso illustrates how vital the role is for patient 
experience and diagnostic communication.
RADIO Meso also identified that providing consulta-
tion time and a conducive environment are fundamental 
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box 7. Preparation and planning
One of the big things that were missing was communication between all the services, effective communication.…. It was my mum phoning the 
doctor who initiated everything else, but by that time it was almost too late. It was like everything was being rushed. And my biggest criticism is that 
there should have been a plan right up front that my mum and dad should have been involved in. (Family carer 9)
We’ve got excellent consultants that are really good at breaking bad news. So in the past we’ve had consultants that haven’t been good at 
breaking bad news and that is what makes the difference. It’s how that’s done. Because that person’s life is changing forever, and how that is 
portrayed to them is so important. So I think we are very lucky in that. We don’t have to pick the pieces up from bad communication, which I have 
done in the past, but we don’t anymore. We’ve got a really good team. (LCNS 3)
It (specialist mesothelioma MDT) will help with the quality of discussion around the management plan. (D 1)
We should be pushing for (trials) but unless we have these MDTs nationally to pool the patients into them then that will be a good way of getting 
recruitment up. (LCNS 1)
box 8. Environment
We aren’t well resourced, but we do insist that we have a room at the clinic. We have to battle when we go into the clinic to get a room, but we do 
insist that we have that room. But it isn’t well resourced, to be honest. It’s a bit of a battle before the clinic starts. (LCNS 4)
But we were just took in a small little room, I don’t even think there was enough chairs for us to sit on, and told it’s mesothelioma, which we 
couldn’t even say, let alone know what it was. (Family carer 1)
box 9. Time
I felt that there was a lot more that could have been done at that initial time …. you’re really left to go away and wait for an appointment. Certainly (I 
would have liked) a longer appointment. (Patient 1)
My mum and dad were in complete shock… But I think they were in such a state that they didn't take a lot in and that was part of the problem, 
we think that that maybe happened too quickly. (Family carer 6)
elements to good practice. This is essential for the 
appointment when a diagnosis is confirmed but also for 
those key clinical encounters before and after the meso-
thelioma confirmation. Staff interview data indicated 
that access to specialist mesothelioma information for 
patients and family aided the diagnostic experience. 
This was enhanced when staff had specialist training in 
mesothelioma and communication. The lack of access to 
follow-up training on communication and mesothelioma 
to emerge from the RADIO Meso findings is a concern.
Good MDT team working and discussion of patient 
cases at an MDT, preferably a specialist mesothelioma 
MDT, were reported to enhance BBN communication.14 
It also helped to instil and maintain hope for patients 
and families following the diagnosis because it was seen 
to streamline access to treatment and trails. The National 
Mesothelioma Audit for England and Wales indicates 
81% of patients were discussed by an MDT, which, while 
positive, did not meet the audit target of 90%. In addi-
tion, there was variation in MDT discussion by network 
with access ranging from 53% to 100%. Such variations 
need to be addressed if diagnostic and treatment expe-
rience is to be enhanced. The contribution of the MDT 
in supporting coping and maintaining hope is a new 
finding.
The findings illustrate how a person-centred approach 
and putting the patient in the centre of diagnostic 
care and communication decisions can have a positive 
impact on patient experience. RADIO Meso shows how 
tailoring communication to the individual’s needs is vital. 
Fundamental to this is the patient feeling that they are 
at the centre of the communication process. This, and 
allocating sufficient time for diagnosis discussions, can 
be challenging within the very real pressures of clinical 
services.
The recommendations focus on communicating a diag-
nosis but it is important to remember that bad news can 
be broken at many points along the diagnostic and care 
pathway. For example, if a patient is informed that they 
are not eligible for a particular treatment or research 
trial that they had invested hope in. The recommenda-
tions may apply to communication at all points that bad 
news is broken.
strengths and weaknesses of the study
RADIO Meso was successful in generating new, in-depth 
insight into the mesothelioma diagnosis experience. 
Integrating patient, family carer and staff experiences 
added to the richness of the insight generated. The use 
of layered methods of individual and group interviews 
plus consultation added to the rigour and strength 
of the study. Reliability and quality were ensured by a 
number of strategies including, digitally recording and 
transcribing interviews, checking and verification of tran-
scripts, and analysis of data by at least two researchers. 
Review of coded transcripts across the research team 
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box 10. Honesty
She didn’t say ‘you’ve got this and that’s it’. She said ‘you’ve got this and this is the options, from radical surgery, there is chemotherapy … So even 
though it was disastrous news in many respects, she gave us a list of things that, you know, like there was a plan around what would happen, as 
opposed to ‘you’ve got a terminal illness’ and that’s it. You know, there was a plan. (Family carer 8)
box 11. Expertise and resources
So, the lung cancer nurse, she was really good, she got me in touch with (Asbestos Support Charity)… and they helped with illing out some DHSS 
forms, and things and that. (Family carer 5)
The specialist nurse took my wife into the ofice and sat her down, and she was obviously very upset. She gave her advice on where she could 
gain counselling and so on. She was very good. (Patient 6)
and discussion regarding interpretation helped generate 
consensus regarding the findings.
The sample did have limitations, including the fact that 
only one doctor volunteered to participate. These data 
were still included as it did add to the range of experi-
ence, along with a support worker who worked alongside 
a LCNS. We aimed to recruit a sample that reflected a 
range of settings, service size, health professional expe-
rience and patient demographic. While the sample 
was small, this aim was achieved and provided in-depth 
data from varied perspectives. We could have recruited 
patients through health professional participants. 
However, different routes of recruitment were used to 
remove the potential risk of data being overly influenced 
by the specific patient/health professional participants 
relationships. For example, we wanted to know about 
patients experiences of receiving a diagnosis of mesothe-
lioma, not the patients experiences of care by a specific 
individual nurse participant.
It was not the purpose of the study to generate statis-
tical data, but to provide understanding of the range of 
experiences of and influences on mesothelioma diagnosis 
communication. The study achieved this aim; however, 
caution is required regarding generalisable claims. The 
findings do resonate with other research regarding BBN 
and diagnosis communication, which does support the 
transferability of the findings.
comparison with other data
RADIO Meso findings reinforce those of Warnock et al10 
in viewing BBN as a process. The studies also both indicate 
the complexity and challenges in BBN in such situations 
as a mesothelioma diagnosis. Warnock et al10 propose a 
framework of factors that influence the ability to break 
bad news including factors relating to situation, organi-
sation, individual and patient/relatives. This framework 
has been supported by the findings presented here.
The importance of staff training and attitudes in 
successful BBN has been identified elsewhere.16 17 The 
3-day advanced communication training recommended 
to staff working in UK cancer services has been shown 
to increase staff confidence and ability.16 RADIO Meso 
emphasises the importance of refreshing and updating 
this training.
The challenge of being honest in communication, while 
maintaining patient and family hope, was highlighted by 
Lelorain et al.17 Similarly, RADIO Meso recognises and 
illustrates this challenge and factors that support it, such 
as access to the specialist nurse, clinical trials and new 
treatments and consistent communication. Getting the 
timing of communication right for individual patients 
also emerged as important in both studies.
The contribution of the CNS to improved quality of 
care and communication across the patient pathway 
has been noted elsewhere, including the field of lung 
cancer.18 19 This study adds to that evidence and articu-
lates the impact of the CNS on effective communication 
of a mesothelioma diagnosis.
Implications of our indings
The RADIO Meso study findings have huge potential 
to influence care and communication related to meso-
thelioma diagnosis communication. To facilitate this, 
the study team have worked with Mesothelioma UK to 
develop recommendations regarding mesothelioma 
diagnosis communication (See figure 2 for these 10 top 
tips).13 These are aspirational in nature and are intended 
to support healthcare workers’ practice with individual 
patients. However, they can also help teams to lobby 
for adequate resources to support diagnosis and care, 
including access to a specialist mesothelioma MDT, CNS 
expertise or appropriate time and environments. The 
recommendations proposed here for mesothelioma may 
well apply in other conditions and settings.
The findings illustrate the complexity of communi-
cating a diagnosis and indicate the need for further 
research to better understand what helps and hinders 
this process.
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